Sun Pharmaceutical Industries Ltd.
4.35 (0.26%) Sun Pharmaceutical Industries reports 8% rise in Q2 consolidated net profit
Date: 01-11-2022Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2022.
The company has reported rise of 49.93% in its net profit at Rs 1213.01 crore for Q2FY23 as compared to Rs 809.07 crore for the corresponding quarter previous year. Total income of the company increased by 20.32% to Rs 5,327.00 crore for the quarter under review as compared to Rs 4,427.42 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported rise of 8.21% in its net profit at Rs 2,260.17 crore for Q2FY23 as compared to Rs 2,088.73 crore for the same quarter in the previous year. Total income of the company increased by 12.07% to Rs 11037.50 crore for the quarter under review as compared to Rs 9,848.82 crore for the same quarter in the previous year.